The inhibition of phosphoinositide synthesis and muscarinic-receptor-mediated phospholipase C activity by Li+ as secondary, selective, consequences of inositol depletion in 1321N1 cells.
about
Synaptic polarity depends on phosphatidylinositol signaling regulated by myo-inositol monophosphatase in Caenorhabditis elegansIQGAP proteins reveal an atypical phosphoinositide (aPI) binding domain with a pseudo C2 domain foldTargeting mutants of PTEN reveal distinct subsets of tumour suppressor functionsSignalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness.The high affinity inositol transport system--implications for the pathophysiology and treatment of bipolar disorder.A screen for novel phosphoinositide 3-kinase effector proteins.A highly dynamic ER-derived phosphatidylinositol-synthesizing organelle supplies phosphoinositides to cellular membranesPharmacogenetics in model systems: defining a common mechanism of action for mood stabilisers.Molecular basis for the integration of inositol phosphate signaling pathways via human ITPK1.Activation of PLC by an endogenous cytokine (GBP) in Drosophila S3 cells and its application as a model for studying inositol phosphate signalling through ITPK1.A cell-permeable tool for analysing APP intracellular domain function and manipulation of PIKfyve activity.Defining signal transduction by inositol phosphates.Fibrinogen - a possible extracellular target for inositol phosphates.The control of phosphatidylinositol 3,4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2.Inositol phospholipids regulate the guanine-nucleotide-exchange factor Tiam1 by facilitating its binding to the plasma membrane and regulating GDP/GTP exchange on Rac1Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.PTEN M-CBR3, a versatile and selective regulator of inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5). Evidence for Ins(1,3,4,5,6)P5 as a proliferative signal.Organization of the receptor-mediated phosphoinositide cycle: relationship between receptor occupancy and accession of phosphatidylinositol.Evidence for a model of integrated inositol phospholipid pools implies an essential role for lipid transport in the maintenance of receptor-mediated phospholipase C activity in 1321N1 cellsMetabolic evidence for PtdIns(4,5)P2-directed phospholipase C in permeabilized plant protoplasts.Muscarinic receptor-mediated activation of p70 S6 kinase 1 (S6K1) in 1321N1 astrocytoma cells: permissive role of phosphoinositide 3-kinase.A novel, rapid, and highly sensitive mass assay for phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) and its application to measure insulin-stimulated PtdIns(3,4,5)P3 production in rat skeletal muscle in vivo.Thrombin receptors modulate insulin-stimulated phosphatidylinositol 3,4,5-trisphosphate accumulation in 1321N1 astrocytoma cells.Is DRM lipid composition relevant in cell-extracellular matrix adhesion structures?Muscarinic receptors mediate phospholipase C-dependent activation of protein kinase B via Ca2+, ErbB3, and phosphoinositide 3-kinase in 1321N1 astrocytoma cells.Inositol 1,3,4-Trisphosphate Actsin Vivoas a Specific Regulator of Cellular Signaling by Inositol 3,4,5,6-Tetrakisphosphate
P2860
Q22336987-CD799E0A-CD21-45CF-B6EE-58B5AFD9E4C0Q24312786-3F617C4C-7D99-4436-B6BB-E58F1FC6B642Q28343581-1B6CA13C-FB1C-42CB-AEB1-1736FA277266Q33809252-04D7FA29-B0CA-4943-B31E-0657D4592AB3Q34185317-56A8ED2D-5AC4-4B5E-BAFF-6BB8B123B9FCQ34751632-0F9099BC-5A15-42A5-BACC-B8CC9CD76034Q35607232-4416ED11-A6F8-47E2-B01B-ECD5142AB64EQ36159850-7A2F04FE-6F40-4AE3-94BD-CA575971072CQ36628646-F4526867-0C8C-440C-82EA-184A4575E8EEQ37586031-D4E21A77-B774-4709-9AF2-7EC225016C58Q37626840-F2B81A11-77B2-4C81-96C4-A583492FF3E2Q37989042-60DF278E-5B7F-4178-8A29-CAA03AFEB131Q38782892-4254640D-DEF9-44FE-B787-F8B83E77BD54Q39252524-1D19A894-3C11-4EDF-B58B-EF1B2FA926EFQ40537882-8D5E124C-26E5-41EB-B504-33E7D42352AAQ40591335-BAF0FF67-F9AD-4A43-86CF-B35A8ADB24BFQ40625753-5A3C0C33-8ABA-44E6-80F4-9F234F9F83B1Q41125297-9FF5A650-7C37-4BBE-AF83-C6201C5EFDCCQ41985733-026961BA-4C8F-4837-B871-62F7BF2A6D0DQ42014402-AAEA4C96-B802-4A81-A319-03C92599E0DFQ42101485-A3DD6D7C-B686-4775-991F-A8D1EA5E9718Q42529173-990AC4D9-F60E-41D6-B1B6-3DDDFDF0687AQ42982936-E6A0470E-A4AC-4974-AEC0-3E394F2BF2D8Q43189884-D0CCAE15-5813-4689-A2DD-DD92FBD0E6C5Q43789257-39387E68-BF55-49F9-A473-18C1E079A7A1Q58538463-00880EB5-01D1-4F17-A3FC-F959AA5121EF
P2860
The inhibition of phosphoinositide synthesis and muscarinic-receptor-mediated phospholipase C activity by Li+ as secondary, selective, consequences of inositol depletion in 1321N1 cells.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
The inhibition of phosphoinosi ...... tol depletion in 1321N1 cells.
@en
The inhibition of phosphoinosi ...... tol depletion in 1321N1 cells.
@nl
type
label
The inhibition of phosphoinosi ...... tol depletion in 1321N1 cells.
@en
The inhibition of phosphoinosi ...... tol depletion in 1321N1 cells.
@nl
prefLabel
The inhibition of phosphoinosi ...... tol depletion in 1321N1 cells.
@en
The inhibition of phosphoinosi ...... tol depletion in 1321N1 cells.
@nl
P2860
P356
P1433
P1476
The inhibition of phosphoinosi ...... tol depletion in 1321N1 cells.
@en
P2093
P2860
P304
P356
10.1042/BJ2970529
P407
P478
297 ( Pt 3)
P577
1994-02-01T00:00:00Z